Speaker illustration

Doctor Bethlehem Mengesha

University of Ottawa Heart Institute, Ottawa (Canada)

Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Congress committee e-posters choice in CAD/ACS/ACC


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb